ERBB2 and breast carcinoma: Human epidermal growth factor receptor 2–positive (HER2+) breast cancer — referring to breast cancer tumors that have HER2, also known as ERBB2, overexpression and/or amplification — accounts for 20%–30% of all breast cancer cases (1).